Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million.

Summary

The bill would establish a state‑run Psilocybin Behavioral Health Access and Therapy Pilot Program, allowing selected hospitals to conduct FDA‑ and DEA‑compliant research on psilocybin for mental‑health conditions. An 11‑member advisory board would guide the program, and $6 million would be appropriated to fund it. The measure was withdrawn and has not advanced.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share